Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
OPEC Fund mobilizes over US$1 billion to advance sustainable development
-
Havila Kystruten AS: Q3 EBITDA Estimate and Compensation Adjustment
-
Outcome of Subscription to Arco Vara AS Bonds
-
Two International Proxy Advisory Firms Support the Governance Project Proposed by OSE Immunotherapeutics at the September 30th General Meeting
-
DTEK subsidiary, DRI, picks Fluence to deliver Trzebinia battery project
-
Wolters Kluwer nominates Rose Lee and Hikmet Ersek for appointment to the Supervisory Board
-
NBPE - Transaction in Own Shares
-
72.5 MW Stelpe solar farm II in Latvia reaches the commercial operation date
-
Two International Proxy Advisory Firms Support the Governance Project Proposed by OSE Immunotherapeutics at the September 30th General Meeting
-
Transaction in own shares
-
A2A Transaction Value to Reach $195 Trillion in 2030 Globally, Driven by Advanced Value-added Services
-
Sampo plc’s share buybacks 19 September 2025
-
CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental and FDA Authorization of the ZEPIZURE® (ZENEO® Midazolam)
-
International Petroleum Corporation to Arrange Fixed Income Investor Meetings
-
Start of Day Message
-
Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis
-
Global expansion of Idorsia’s QUVIVIQ continues as Simcere launches in China
-
Ipsen’s LANTIC Phase II in aesthetics delivers a first-in-class, differentiated long-acting clinical profile for IPN10200, enabling the initiation of Phase III
-
Positive phase III results show Roche’s giredestrant significantly improved progression-free survival in ER-positive advanced breast cancer
-
Prosafe SE: Operational update – August 2025
-
Corbion reports the progress of its share buyback program 15 September – 19 September 2025
-
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
-
Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion
-
CEA Industries Files Registration Statement for its $500M PIPE. CEO David Namdar Releases Letter to Shareholders
-
ICEX and SOSA Launch Desafía San Francisco to Accelerate Spanish Startups in Silicon Valley
-
Faraday Future Announced a Total Strategic Investment of $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) During its Annual 919 Event, for its Crypto Business Focusing on Three Growth Engines
-
BW Offshore: First Gas achieved on the BW Opal FPSO
-
Senator Ted Cruz Officiates USTDA Grant Signing with Terra Metals Inc. and Metalex Commodities for Zambia’s Kazozo Copper–Cobalt Project
-
Solana Observers Add MAGACOIN FINANCE to Presale Market Narratives
-
Bitcoin and XRP Market Coverage Reflect Mentions of MAGACOIN FINANCE
-
Ethereum-Based MAGACOIN FINANCE Positioned for Attention in 2025 Investor Outlooks
-
Best THCA Flower: NexZen Extracts Showcases Premium Strains for Hemp Enthusiasts Nationwide
-
Senior Care Expert Beth Bigham of Greenwood Explains Equine Therapy in Indianapolis for HelloNation
-
Retirement Planning Expert Robert Carey Shares Guidance on What to Do Before a 401(k) Rollover in HelloNation
-
Real Estate Expert Bart Hickman Shares Seasonal Tips for Lake Shafer and Lake Freeman Buyers in HelloNation
-
Ethereum-Based DeFi Crypto Mutuum Finance (MUTM) Raises Over $16 Million With More Than 720M Tokens Sold
-
Bitcoin Investors Join XRP Tundra Presale With Target Launch Price of $2.50
-
Mutuum Finance (MUTM) Raises $16 Million While Advancing Toward Platform Release
-
URBANICA Furniture Brings Premium Ergonomic Office Solutions Direct to Consumers at Up to 50% Savings
-
LiTime’s European Debuts at the 2025 Il Salone del Camper: Spotlight on the H190 Series Batteries, Engineered to Fit the Unique Space and Energy Demands of motorhomes
-
Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
-
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with N
-
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDS
-
XRP-Connected Market Narratives Reference MAGACOIN FINANCE Ahead of Presale Milestones
-
Gold IRA Rollover Guide: How to Convert an IRA or 401(k) to Gold, Explained by Clute Journals
-
Cardano Rival MAGACOIN FINANCE Gains Presence in Global Altcoin Commentary
-
Solana and XRP Market Reports Highlight MAGACOIN FINANCE as an Early Contender
-
Goldragon Launches Next-Gen GameFi Ecosystem on BNB Chain with RWA-Backed Staking & Governance Tools
-
Tracer Launches Initial Exchange Offering on Coinstore: Building a Trusted RWA Ecosystem for Carbon Removal
-
AIMOON – AI-Powered Web3 Agent Platform for Deploying Intelligent Agents

